This inventor holds 1 USPTO granted patent. Top assignee: University of Florida Research Foundation Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Adam B Grossman: Innovator in Aqueous Lignin Solutions
Introduction
Adam B Grossman is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biomedical research through his innovative work on lignin solvation. His research focuses on creating aqueous lignin solutions that have a wide range of applications.
Latest Patents
Adam B Grossman holds a patent for "Lignin solvation using aqueous biologically compatible buffers." This patent describes the provision of aqueous lignin solutions containing lignin solvated in Good's Buffers. These solutions can be utilized in various applications, including biomedical research and the manufacturing of lignin-containing products, such as food-grade and biomedical products. Additionally, the aqueous lignin solutions can be employed in the treatment of microbial infections, as an adjuvant in antimicrobial therapeutics, and in the formation of antimicrobial products. The patent also outlines methods for making and using these aqueous lignin solutions.
Career Highlights
Adam is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research. His work has garnered attention for its potential impact on both scientific research and practical applications in various industries.
Collaborations
He has collaborated with notable colleagues, including Kelly C Rice and Willem Evert Vermerris, who have contributed to his research endeavors.
Conclusion
Adam B Grossman is a pioneering inventor whose work on aqueous lignin solutions holds promise for numerous applications in biomedical and manufacturing fields. His contributions are paving the way for innovative solutions in the treatment of microbial infections and the development of new products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
